Catalyst Wire Dossier Catalyst Wire Dossier

rolapitant hydrochloride

rolapitant hydrochloride
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rolapitant hydrochloride, covering 2021-08-09 to 2021-08-09. Get the full timeline:

Most recent: Clinical Trial Update: Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy [Phase 2]

See pricing